Heino M, Scott H S, Chen Q, Peterson P, Mäebpää U, Papasavvas M P, Mittaz L, Barras C, Rossier C, Chrousos G P, Stratakis C A, Nagamine K, Kudoh J, Shimizu N, Maclaren N, Antonarakis S E, Krohn K
Institute of Medical Technology, University of Tampere, Finland.
Hum Mutat. 1999;13(1):69-74. doi: 10.1002/(SICI)1098-1004(1999)13:1<69::AID-HUMU8>3.0.CO;2-6.
Autoimmune polyendocrinopathy syndrome type 1 (APS-1; MIM# 240300) is a rare autosomal recessively inherited disease characterised by destructive autoimmune diseases of endocrine glands. The gene responsible for APS-1, known as AIRE (for autoimmune regulator), was recently identified and contains motifs suggestive of a transcription regulator. To date, nine APS-1-associated mutations have been identified in the AIRE gene, including two common mutations R257X and 1094-1106del. In addition to these two mutations, we report seven novel mutations in 16 APS-1 patients from North America. We found that 1094-1106del and R257X were the most common mutations in this population of mixed geoethnic origin, accounting for 17/32 and 4/32 alleles, respectively. Haplotype analyses suggest that both are recurrent mutations, occurring on several different haplotypes with closely linked markers. All the novel mutations appear to be rare, occurring in only single APS-1 families. After examining all coding sequences and exon/intron boundaries of the AIRE gene, the other APS-1 allele remained unidentified in three patients. Genotype-phenotype correlations for APS-1 remain difficult, suggesting that other genetic or environmental factors, or both, influence the clinical presentation and disease progression in individual APS-1 patients.
1型自身免疫性多内分泌腺病综合征(APS-1;MIM# 240300)是一种罕见的常染色体隐性遗传病,其特征为内分泌腺的自身免疫性破坏性疾病。导致APS-1的基因,即自身免疫调节因子(AIRE),最近已被确定,该基因含有提示转录调节因子的基序。迄今为止,已在AIRE基因中鉴定出9种与APS-1相关的突变,包括两种常见突变R257X和1094-1106del。除了这两种突变外,我们报告了来自北美的16例APS-1患者中的7种新突变。我们发现,在这个混合地理种族来源的人群中,1094-1106del和R257X是最常见的突变,分别占32个等位基因中的17个和4个。单倍型分析表明,这两种都是复发性突变,出现在几种不同的单倍型上,标记紧密连锁。所有新突变似乎都很罕见,仅在单个APS-1家族中出现。在检查了AIRE基因的所有编码序列和外显子/内含子边界后,3例患者的另一个APS-1等位基因仍未确定。APS-1的基因型-表型相关性仍然难以确定,这表明其他遗传或环境因素,或两者兼而有之,会影响个体APS-1患者的临床表现和疾病进展。